Iowa Opioid Fund & Emerging Alkaloid Policy Explorer

Grounded in Iowa's announced $1,600,000 opioid epidemic grant distribution and emerging state-federal tensions over concentrated 7-hydroxymitragynine (7-OH) isolates. Model budget allocations, toxicological laboratory screening capacities, receptor affinity differentials, and state regulatory regimes.

Overdose Aversion Index
76.2
Composite prevention & rapid-response rating (0-100)
Unregulated Retail Drop
64.0%
Projected reduction in illicit/grey gas-station concentrate sales
Surveillance Screens / Mo
420
Mass spectrometry screens for adulterants & 7-OH isolates
Treatment Capacity Surge
+18.4%
Statewide MAT & clinical detox bed throughput increase

$1.6M Fund Allocation Matrix

$1,600,000
Clinical Treatment Beds 30% ($480k)
Medication-Assisted Treatment (MAT) facilities & crisis stabilization
Lab Surveillance & MS Testing 25% ($400k)
High-resolution LC-MS screens for novel synthetic opioids & pure 7-OH
Naloxone & Harm Reduction 30% ($480k)
Direct community distribution, fentanyl test strips, first-responder kits
Public Warning & Education 15% ($240k)
Youth warnings, point-of-sale advisories, alkaloid dependency education

Iowa 7-OH Regulatory Regime Model

Status: Modeling balanced harm reduction under active 21+ purity standards.

Dynamic Allocation Flow & Comparative Pharmacology

Distribution graph dynamically maps live grant disbursements against state intervention targets. Higher toxicology investments directly increase monthly hospital and street surveillance throughput.

Enjoy this tool? Build your own with Super